Importantly, treatment with anti‐VAPA antibodies or the 187‐1 (LOs/187‐1) markedly prevented VAPA‐enriched LOs‐induced bone pre‐metastatic niche formation and HCC bone‐metastasis. The gene discussed is VAPA; the disease is hepatocellular carcinoma.